FTC settlement with Cephalon over Provigil pay-for-delay claims will send signal to industry, Ramirez says
The Federal Trade Commission’s $1.2 billion settlement with Cephalon over claims that the company illegally delayed generic versions of its sleep disorder drug Provigil “will send a signal” to the pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article